| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000042747 |
| Receipt No. | R000048764 |
| Scientific Title | The effect of milk protein intake and exercise practice on lower limb functions, autonomic nervous system and hemoglobin in older adults with a lower limb functions |
| Date of disclosure of the study information | 2022/03/31 |
| Last modified on | 2022/06/17 (Ver. 2) |
| Basic information | ||
| Public title | The effect of milk protein intake and exercise practice on lower limb functions, autonomic nervous system and hemoglobin in older adults with a lower limb functions | |
| Acronym | The effect of milk protein intake and exercise practice on lower limb functions, autonomic nervous system and hemoglobin | |
| Scientific Title | The effect of milk protein intake and exercise practice on lower limb functions, autonomic nervous system and hemoglobin in older adults with a lower limb functions | |
| Scientific Title:Acronym | The effect of milk protein intake and exercise practice on lower limb functions, autonomic nervous system and hemoglobin | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteers | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of milk protein intake and exercise practice on lower limb functions, autonomic nervous system and hemoglobin in older adults with lower limb functions |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 12 weeks after the start of food intake and exercise practice intervention
Strength of lower limbs during sit-to-stand |
| Key secondary outcomes | 1) One-leg standing with eyes open
2) Sit and reach 3) Timed up and go 4) 5-m habitual walk 5) Autonomic nervous 6) Hemoglobin 7) Body compositions (height, weight, muscle mass, fat mass, bone mass) 8) Visual Analogue Scale (VAS) of bodily sensation 9) Cognitive functions: Trail Making Peg Test (TMP: executive functions), Five cognitive function test(attention, verbal memory, visuospatial cognition, word fluency, associate learning) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | 12 weeks of milk protein intake (5g/twice daily (breakfast/dinner) | |
| Interventions/Control_2 | 12 weeks of milk protein intake (5g/twice daily (breakfast/dinner) and exercise practice (3 times/week at home (walking: 30 minutes + weight-bearing exercises: 20 minutes + stretching: 10 minutes)) | |
| Interventions/Control_3 | Control(No treatment) | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subjects without prohibition on exercise from a doctor
2) Subjects with the capacity to participate the study-related briefing sessions, examinations and measurements in University of Tsukuba by themselves |
|||
| Key exclusion criteria | 1) Subjects with paralysis
2) Subjects with allergies to supplements, milk components and soybean 3) Subjects who are involving in other clinical experiments currently or having participated in any other clinical experiments in the past 3 months 4) Subjects excluded as inappropriate participants by the lead principal investigator |
|||
| Target sample size | 72 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Faculty of Health and sport science | ||||||
| Zip code | 305-8574 | ||||||
| Address | 1-1-1 Tennodai, Tsukuba | ||||||
| TEL | 029-859-2733 | ||||||
| okura.tomohiro.gp@u.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Industry-University Collaboration R&D Center for Tailor-Made QOL | ||||||
| Zip code | 305-8550 | ||||||
| Address | Innovation Medical Research Institute, Laboratory No. 407 1-2 Kasuga, Tsukuba, Ibaraki | ||||||
| TEL | 029-859-1834 | ||||||
| Homepage URL | |||||||
| mjmj0816@gmail.com | |||||||
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Morinaga Milk Industry Company Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | University of Tsukuba |
| Address | 1-1-1 Tennodai, Tsukuba |
| Tel | 029-853-2571 |
| tg-kenkyu@un.tsukuba.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 筑波大学(茨城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000048764 |